JF
Jonathan Fallowfield
Member of Clinical Advisory Board – Liver cirrhosisProf. Jonathan Fallowfield, MD PhD, is Member of Clinical Advisory Board – Liver cirrhosis of Damora Therapeutics, Inc. (formerly known as Galecto, Inc.) Prof. Fallowfield was Member of the Clinical Advisory Board - NASH of Damora Therapeutics, Inc. (formerly known as Galecto, Inc.) Prof. Fallowfield is a Professor of Edinburgh University. Prof. Fallowfield serves as a Member of Scientific Advisory Board at Resolution Therapeutics Limited.
Positions
- Company NameDamora Therapeutics, Inc.Stock CodeDMRAPositionMember of Clinical Advisory Board – Liver cirrhosisColleagues
- GWGarrett WinslowSenior VP, General Counsel & Corporate Secretary
- PEPeter Evan HarwinIndependent Chairman of the Board
- JAJennifer A. JarrettCEO, President & Director
- UJUlf J. NilssonCo-Founder
- HLHakon LefflerCo-Founder
- TSTariq SethiCo-Founder
- CWChristopher W. CainIndependent Director
- MLMichael LandsittelIndependent Director
